New Leadership to Drive Strategic Growth in the Americas Region
Evonik Appoints Elias Lacerda as President of the Americas Following the Merger of Two Sub-Regions
Evonik, a global specialty chemicals company, has named executive Elias Lacerda President of the Americas region, effective February 1, 2026. Lacerda will succeed Guido Skudlarek, who recently became the global Head of Evonik’s U.S.-based Health Care business line.
Strategic Importance of the Americas Region:
The Americas region is crucial for Evonik’s success, generating 30% of the company’s annual revenue. The region currently hosts more than 30 production sites, along with distribution centers and commercial offices. This appointment follows Evonik’s decision to merge the Central and South America (CSA) regions with North America.
Personal Profile and Experience:
-
Experience: Lacerda, a native Brazilian, has nearly three decades of experience with Evonik and its predecessors. He spent half of that time managing coatings businesses in Central and South America (CSA) and held global leadership roles in Evonik’s Silica and Animal Nutrition business lines.
-
Prior Roles: He previously led the CSA region as president from 2018 to 2022. Most recently, he served as the head of the Coating Additives business line at the company’s headquarters in Essen, Germany.
-
Assessment: Evonik’s leadership considers Lacerda the perfect choice, citing his fluency in four languages, extensive global network, and an ideal combination of scientific and business expertise.
Evonik’s leadership expressed confidence that Lacerda will guide the company through its next phase of growth trajectory in North and South America, where the company sees great potential and holds ambitious goals.
Source: https://www.contractpharma.com/breaking-news/evonik-appoints-president-for-the-americas-region/
